Vaishali Shinde

Author PubWeight™ 9.24^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays.	Clin Cancer Res	2011	2.35
2	Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity.	Cancer Res	2007	1.62
3	Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.	Mol Cancer Ther	2010	1.07
4	Gnidia glauca flower extract mediated synthesis of gold nanoparticles and evaluation of its chemocatalytic potential.	J Nanobiotechnology	2012	0.98
5	Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.	Cancer Res	2010	0.92
6	Response to MLN8237 in pancreatic cancer is not dependent on RalA phosphorylation.	Mol Cancer Ther	2013	0.91
7	MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma.	Mol Cancer Ther	2012	0.80
8	Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905).	J Med Chem	2011	0.80